Regent Peak Wealth Advisors LLC Astrazeneca PLC Transaction History

Regent Peak Wealth Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$47.16 - $54.44 $120,918 - $139,584	-2,564 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $124,405 - $148,763	2,564 New	2,564 $128,000
Q1 2020 Apr 27, 2020	SELL	$37.79 - $51.33 $215,403 - $292,581	-5,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $242,022 - $287,622	5,700 New	5,700 $284,000

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Regent Peak Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Regent Peak Wealth Advisors LLC with notifications on news.